Filing Details

Accession Number:
0001209191-20-016235
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-04 17:06:56
Reporting Period:
2020-03-02
Accepted Time:
2020-03-04 17:06:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1748907 Orchard Therapeutics Plc ORTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1793992 Bobby Gaspar C/O Orchard Therapeutics Plc
108 Cannon Street
London X0 EC4N 6EU
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-03-02 4,921 $0.00 353,240 No 4 M Direct
Ordinary Shares Disposition 2020-03-02 4,921 $13.00 348,319 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-03-02 4,921 $0.00 4,921 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
597,867 2026-09-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 2,000 Indirect By Reporting Person's Child
Ordinary Shares 2,000 Indirect By Reporting Person's Child
Footnotes
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. 150,697 shares subject to this option vested on February 1, 2017 and the remaining shares vest in equal monthly installments over the three years thereafter.